Author:
Meng Qianqian,Wang Shuyuan,Zhou Shunheng,Liu Haizhou,Ma Xueyan,Zhou Xu,Liu Hui,Xu Chaohan,Jiang Wei
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology,Genetics,Molecular Medicine
Reference50 articles.
1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.
2. Chunhacha P, Chanvorachote P. Roles of caveolin-1 on anoikis resistance in non small cell lung cancer. Int J Physiol Pathophysiol Pharmacol. 2012;4:149–55.
3. Herbst RS, Heymach JV, Lippman SM. Lung cancer. New Engl J Med. 2008;359:1367–80.
4. Keating GM. Afatinib: a review in advanced non-small cell lung cancer. Target Oncol. 2016;11:825–35.
5. Schuler M, Wu YL, Hirsh V, O’Byrne K, Yamamoto N, Mok T, et al. First-line afatinib versus chemotherapy in patients with non-small cell lung cancer and common epidermal growth factor receptor gene mutations and brain metastases. J Thorac Oncol. 2016;11:380–90.
Cited by
29 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献